Obesity pharmacotherapy, multidisciplinary weight-loss program effective in ‘real world’ setting
Patients were prescribed the combination of phentermine and topiramate ER (34.3%), liraglutide (1.8 mg 17.4% and 3.0 mg 3.4%), topiramate (12.4%), the combination of naltrexone and bupropion SR (11.2%), phentermine (11.2%), lorcaserin (5.6%), and metformin (4.5%)
https://www.healio.com/gastroenterology/nutrition/news/online/%7B58a282d6-8149-4d85-8513-53b5cd87a49d%7D/obesity-pharmacotherapy-multidisciplinary-weight-loss-program-effective-in-real-world-setting
Patients were prescribed the combination of phentermine and topiramate ER (34.3%), liraglutide (1.8 mg 17.4% and 3.0 mg 3.4%), topiramate (12.4%), the combination of naltrexone and bupropion SR (11.2%), phentermine (11.2%), lorcaserin (5.6%), and metformin (4.5%)
https://www.healio.com/gastroenterology/nutrition/news/online/%7B58a282d6-8149-4d85-8513-53b5cd87a49d%7D/obesity-pharmacotherapy-multidisciplinary-weight-loss-program-effective-in-real-world-setting